Literature DB >> 15210452

Oxygen delivery and consumption in the microcirculation after extreme hemodilution with perfluorocarbons.

Pedro Cabrales1, Amy G Tsai, John A Frangos, Juan C Briceño, Marcos Intaglietta.   

Abstract

The oxygen transport capacity of fluorocarbons was investigated in the hamster chamber window model microcirculation to determine the rate at which oxygen is delivered to the tissue in conditions of extreme hemodilution [hematocrit (Hct) 11%]. Hydroxyethlyl starch (HES 200; 200 kDa molecular mass) was used as a plasma expander for two isovolemic hemodilutions performed with 10% HES 200 until a Hct of 65%. A third step reduced the Hct to 75% of baseline and was performed with either HES 200 or a 60% perfluorocarbon (PFC) emulsion. Comparisons of HES 200-only-hemodiluted animals versus 4.2 g/kg PFC emulsion-hemodiluted animals were made at 21% and 100% normobaric oxygen ventilation. It was found that systemic and microvascular oxygen delivery was 25% and 400% higher in the PFC animals compared with HES 200 animals, respectively, showing that PFCs deliver oxygen to the tissue when combined with hyperoxic ventilation in the present experiments, with no evidence of vasoconstriction or impaired microvascular function. Oxygen ventilation (100%) led to a positive base excess for the PFC group (5.5 +/- 2.5 mmol/l) versus a negative balance (-0.8 +/- 1.4 mmol/l) for the HES 200 group, suggesting that microvascular findings corresponded to systemic events.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210452     DOI: 10.1152/ajpheart.01166.2003

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  16 in total

1.  Hypervolemic infusion of Lumbricus terrestris erythrocruorin purified by tangential-flow filtration.

Authors:  Jacob Elmer; Katie Zorc; Shahid Rameez; Yipin Zhou; Pedro Cabrales; Andre F Palmer
Journal:  Transfusion       Date:  2012-02-05       Impact factor: 3.157

2.  Effects of the molecular mass of tense-state polymerized bovine hemoglobin on blood pressure and vasoconstriction.

Authors:  Pedro Cabrales; Guoyong Sun; Yipin Zhou; David R Harris; Amy G Tsai; Marcos Intaglietta; Andre F Palmer
Journal:  J Appl Physiol (1985)       Date:  2009-09-10

3.  Tissue oxidative metabolism after extreme hemodilution with PEG-conjugated hemoglobin.

Authors:  Pedro Cabrales; Fantao Meng; Seetharama A Acharya
Journal:  J Appl Physiol (1985)       Date:  2010-09-02

Review 4.  Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.

Authors:  Pedro Cabrales; Marcos Intaglietta
Journal:  ASAIO J       Date:  2013 Jul-Aug       Impact factor: 2.872

5.  Transport of nitric oxide by perfluorocarbon emulsion.

Authors:  Daniel Ortiz; Pedro Cabrales; Juan C Briceño
Journal:  Biotechnol Prog       Date:  2013-09-10

6.  Modulation of perfusion and oxygenation by red blood cell oxygen affinity during acute anemia.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  Am J Respir Cell Mol Biol       Date:  2007-09-20       Impact factor: 6.914

7.  Isovolemic exchange transfusion with increasing concentrations of low oxygen affinity hemoglobin solution limits oxygen delivery due to vasoconstriction.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-03       Impact factor: 4.733

8.  Balance between vasoconstriction and enhanced oxygen delivery.

Authors:  Pedro Cabrales; Amy G Tsai; Marcos Intaglietta
Journal:  Transfusion       Date:  2008-07-09       Impact factor: 3.157

9.  In vitro alteration of hematological parameters and blood viscosity by the perfluorocarbon: Oxycyte.

Authors:  Françoise Arnaud; Katherine Sanders; Donna Sieckmann; Paula Moon-Massat
Journal:  Int J Hematol       Date:  2016-02-17       Impact factor: 2.490

10.  Hemoglobin encapsulated poly(ethylene glycol) surface conjugated vesicles attenuate vasoactivity of cell-free hemoglobin.

Authors:  Pedro Cabrales; Shahid Rameez; Andre F Palmer
Journal:  Curr Drug Discov Technol       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.